These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 28287886)
1. Overexpressed connective tissue growth factor in cardiomyocytes attenuates left ventricular remodeling induced by angiotensin II perfusion. Zhang Y; Yan H; Guang GC; Deng ZR Clin Exp Hypertens; 2017; 39(2):168-174. PubMed ID: 28287886 [TBL] [Abstract][Full Text] [Related]
2. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure. Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123 [TBL] [Abstract][Full Text] [Related]
3. CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload. Gravning J; Ahmed MS; von Lueder TG; Edvardsen T; Attramadal H Int J Cardiol; 2013 Oct; 168(3):2049-56. PubMed ID: 23452880 [TBL] [Abstract][Full Text] [Related]
4. [Expression of connective tissue growth factor in cardiomyocyte of young rats with heart failure and benazepril intervention]. Zhang Q; Yi QJ; Qian YR; Li R; Deng B; Wang Q Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):733-7. PubMed ID: 17229371 [TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis. Wong CKS; Falkenham A; Myers T; Légaré JF J Renin Angiotensin Aldosterone Syst; 2018; 19(1):1470320318759358. PubMed ID: 29575960 [TBL] [Abstract][Full Text] [Related]
6. Regulation and role of connective tissue growth factor in AngII-induced myocardial fibrosis. Rosin NL; Falkenham A; Sopel MJ; Lee TD; Légaré JF Am J Pathol; 2013 Mar; 182(3):714-26. PubMed ID: 23287510 [TBL] [Abstract][Full Text] [Related]
7. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice. Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623 [TBL] [Abstract][Full Text] [Related]
12. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart. Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869 [TBL] [Abstract][Full Text] [Related]
13. Connective tissue growth factor/CCN2 attenuates β-adrenergic receptor responsiveness and cardiotoxicity by induction of G protein-coupled receptor kinase-5 in cardiomyocytes. Gravning J; Ahmed MS; Qvigstad E; Krobert K; Edvardsen T; Moe IT; Hagelin EM; Sagave J; Valen G; Levy FO; Osnes JB; Skomedal T; Attramadal H Mol Pharmacol; 2013 Sep; 84(3):372-83. PubMed ID: 23778361 [TBL] [Abstract][Full Text] [Related]
14. Effect of farnesyltransferase inhibition on cardiac remodeling in spontaneously hypertensive rats. Li X; Han J; Li L; Wang KJ; Hu SJ Int J Cardiol; 2013 Oct; 168(4):3340-7. PubMed ID: 23664044 [TBL] [Abstract][Full Text] [Related]
15. Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan. Iwamoto M; Hirohata S; Ogawa H; Ohtsuki T; Shinohata R; Miyoshi T; Hatipoglu FO; Kusachi S; Yamamoto K; Ninomiya Y Hypertens Res; 2010 Dec; 33(12):1305-11. PubMed ID: 20944640 [TBL] [Abstract][Full Text] [Related]
16. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload. Fontes MS; Kessler EL; van Stuijvenberg L; Brans MA; Falke LL; Kok B; Leask A; van Rijen HV; Vos MA; Goldschmeding R; van Veen TA J Mol Cell Cardiol; 2015 Nov; 88():82-90. PubMed ID: 26410398 [TBL] [Abstract][Full Text] [Related]
17. Deletion of protein kinase B2 preserves cardiac function by blocking interleukin-6-mediated injury and restores blood pressure during angiotensin II/high-salt-diet-induced hypertension. Yang S; Chen D; Chen F; Zhao X; Zhang Y; Li Z; Jin L; Xu Y; Sanchis D; Ye J J Hypertens; 2018 Apr; 36(4):834-846. PubMed ID: 29120957 [TBL] [Abstract][Full Text] [Related]
18. Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction. Misaka T; Suzuki S; Miyata M; Kobayashi A; Ishigami A; Shishido T; Saitoh S; Kubota I; Takeishi Y Biochem Biophys Res Commun; 2013 Sep; 439(1):142-7. PubMed ID: 23933320 [TBL] [Abstract][Full Text] [Related]
19. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice. Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827 [TBL] [Abstract][Full Text] [Related]
20. Liraglutide improves myocardial fibrosis after myocardial infarction through inhibition of CTGF by activating cAMP in mice. Huang DD; Huang HF; Yang Q; Chen XQ Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4648-4656. PubMed ID: 30058704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]